CYTK : Summary for Cytokinetics, Incorporated - Yahoo Finance

U.S. Markets closed

Cytokinetics, Incorporated (CYTK)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.25+0.70 (+5.17%)
At close: 4:00PM EDT
People also watch
CORTGTXIARRYCRISCYCC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close13.55
Open13.60
Bid13.90 x 300
Ask14.35 x 1800
Day's Range13.40 - 14.35
52 Week Range7.18 - 14.35
Volume2,120,943
Avg. Volume471,169
Market Cap616.19M
Beta2.04
PE Ratio (TTM)36.54
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 days ago

    Cytokinetics Added to S&P SmallCap 600

    SOUTH SAN FRANCISCO, Calif., April 21, 2017-- Cytokinetics today announced it has been selected for addition to the S&P SmallCap 600 GICS Biotechnology Sub-Industry Index. The index, a member of the Dow ...

  • Capital Cube3 days ago

    Cytokinetics, Inc. – Value Analysis (NASDAQ:CYTK) : April 20, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Cytokinetics, Inc. a score of 93. Our analysis is based on comparing Cytokinetics, Inc. with the following peers – ARCA biopharma, Inc., Ligand Pharmaceuticals Incorporated, GTx, Inc., Trevena, Inc., Acorda Therapeutics, Inc., Amgen Inc., ArQule, Inc., Eiger BioPharmaceuticals, Inc. and Array BioPharma Inc. (ABIO-US, LGND-US, GTXI-US, TRVN-US, ... Read more (Read more...)

  • Cytokinetics, Inc.: Leads amongst peers with strong fundamentals
    Capital Cube4 days ago

    Cytokinetics, Inc.: Leads amongst peers with strong fundamentals

    Categories: Yahoo FinanceCytokinetics, Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 93. Our analysis is based on comparing Cytokinetics, Inc. with the following peers – ARCA biopharma, Inc., Ligand Pharmaceuticals Incorporated, GTx, Inc., Trevena, Inc., Acorda Therapeutics, Inc., Amgen Inc., ArQule, Inc., Eiger BioPharmaceuticals, Inc. and Array BioPharma Inc. (ABIO-US, LGND-US, GTXI-US, ... Read more (Read more...)